measured B12 levels in 51 mothers, placentas, and infants post-delivery, and found that the intervillous space in the placenta contained a higher concentration of B12 (796 pmol/l) than the blood of the mothers (590 pmol/l) or their newborns (252 pmol/l)
If the FDA does forge ahead and open the gates to a peptide flood, we will learn more as more people take them
Patient-focused dispensing triggers stricter documentation and professional review
Supports proper hormone production, balance, and mood May reduce high blood levels of homocysteine (a substance thought to contribute to heart disease when elevated)
In documentation review, researchers should compare the full compound name, shorthand naming, chemical form, and COA details against identity records
The systems rigidity is prioritizing administrative ease over patient well-being